##################################################################################
# Document Properties
##################################################################################
SET DOCUMENT Name = "32216698.bel"
SET DOCUMENT Authors = "Shounak Baksi"
SET DOCUMENT ContactInfo = "shounak.baksi@causalitybiomodels.com"
SET DOCUMENT Description = "COVID Knowledge Curation project"

SET DOCUMENT Licenses = "Private Ownership to Fraunhofer Institute SCAI"
SET DOCUMENT Copyright = "Copyright Â© 2020 Fraunhofer Institute SCAI, All rights reserved"
SET DOCUMENT Version = "2.0.0"

##################################################################################
# NAMESPACES Section
##################################################################################

# DEFINE NAMESPACE ADO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/alzheimer-disease-ontology/alzheimer-disease-ontology-1.0.2.belns"
# DEFINE NAMESPACE BRCO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/brain-region-ontology/brain-region-ontology-1.0.0.belns"
# DEFINE NAMESPACE NIFT AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/nift/NIFT.belns"

DEFINE NAMESPACE HGNC AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc/hgnc-20190708.belns"
# DEFINE NAMESPACE MGI AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20190128.belns"
# DEFINE NAMESPACE RGD AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/rgd-rat-genes/rgd-rat-genes-20190128.belns"
# DEFINE NAMESPACE GFAM AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc-gene-families/hgnc-genefamily-names-20181221.belns"
# DEFINE NAMESPACE SCOMP AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20190128.belns"
# DEFINE NAMESPACE SFAM AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20190128.belns"
DEFINE NAMESPACE HP AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20190130.belns"
DEFINE NAMESPACE CHEBI AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns"
# DEFINE NAMESPACE DRUGBANK AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/drugbank/drugbank-20180906.belns"
# DEFINE NAMESPACE INTERPRO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/interpro/interpro-names-20181021.belns"
# DEFINE NAMESPACE PFAM AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/pfam/pfam-names-20181024.belns"
DEFINE NAMESPACE DO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20200407.belns"
DEFINE NAMESPACE GO AS URL 	"https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go/go-20180109.belns"
# DEFINE NAMESPACE GOBP AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-biological-process/go-biological-process-20190128.belns"
# DEFINE NAMESPACE GOCC AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-cellular-component/go-cellular-component-20190128.belns"
DEFINE NAMESPACE EFO AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/efo/efo-20171206.belns"
DEFINE NAMESPACE MESH AS URL 	"https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh/mesh-names-20181007.belns"

# DEFINE NAMESPACE MESHC AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-chemicals/mesh-chemicals-20190128.belns"
# DEFINE NAMESPACE MESHD AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-diseases/mesh-diseases-20190128.belns"
# DEFINE NAMESPACE MESHPP AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-processes/mesh-processes-20190128.belns"
# DEFINE NAMESPACE MESHA AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-anatomy/mesh-anatomy-20190128.belns"
# DEFINE NAMESPACE MESHCS AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-cellular-structures/mesh-cellular-structures-20190128.belns"
# DEFINE NAMESPACE NCBIGENE AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-gene/ncbi-gene-20190224.belns"
# DEFINE NAMESPACE NCBITAXON AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-taxonomy/ncbi-taxonomy-20200322.belns"
DEFINE NAMESPACE COVID AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-covid19/ncbi-covid19-20200326.belns"
# DEFINE NAMESPACE UNIPROT AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
# DEFINE NAMESPACE PUBCHEM AS PATTERN "^\d+$"
# DEFINE NAMESPACE dbSNP AS PATTERN "rs[0-9]+"

##################################################################################
# ANNOTATIONS Section
##################################################################################
# DEFINE ANNOTATION Anatomy AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20190128.belanno"
# DEFINE ANNOTATION CellLine AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20190128.belanno"
# DEFINE ANNOTATION Cell AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20190128.belanno"
# DEFINE ANNOTATION Disease AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20190128.belanno"
DEFINE ANNOTATION MeSHAnatomy AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20190128.belanno"
# DEFINE ANNOTATION MeSHDisease AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20190128.belanno"
DEFINE ANNOTATION Species AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/species-taxonomy-id/species-taxonomy-id-20170511.belanno"
# DEFINE ANNOTATION TextLocation AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
# DEFINE ANNOTATION BioAssay AS PATTERN ".*"

DEFINE ANNOTATION Custom_Disease AS LIST {"COVID-19"}
DEFINE ANNOTATION Severity AS LIST {"Severe"}
DEFINE ANNOTATION Disease_Stage AS LIST {"Early", "Late"}

# Document Annotations #
DEFINE ANNOTATION PublicationType AS LIST {"Review", "Research"}
DEFINE ANNOTATION PublicationStatus AS LIST {"Preprint", "Published"}
DEFINE ANNOTATION Section AS LIST {"Full Text", "Abstract", "Results"}

##################################################################################
# Statements #
##################################################################################

SET Citation = {"PubMed","32216698"}
SET PublicationType = "Review"
SET PublicationStatus = "Published"
SET Section = "Results"
SET Custom_Disease = "COVID-19"
SET Species = "9606"

SET Evidence = "The existence of significantly increased fibrin-degraded products and \
reduced platelets in severe COVID-19 patients is consistent with the \
presence of hyper-fibrinolysis."

SET Severity = "Severe"
deg(a(CHEBI:Fibrin)) pos path(HP:Hyperfibrinolysis)
bp(MESH:"Platelet Count") neg path(HP:Hyperfibrinolysis)
path(HP:Hyperfibrinolysis) pos path(EFO:pathogenicity)

SET Evidence = "This opinion is supported by the presence of hemorrhage in multiple \
organs and a positive correlation between fibrinolysis and mortality."

path(MESH:Hemorrhage) pos deg(a(CHEBI:Fibrin))
path(MESH:Hemorrhage) pos path(MESH:Mortality)
UNSET Severity

SET Evidence = "Plasmin, a key player in fibrinolysis, enhances the virulence and \
pathogenicity of viruses containing a furin site in their envelope \
proteins, as is the case with the SARS-CoV-2."

act(p(HGNC:PLG)) -> deg(a(CHEBI:Fibrin))
deg(a(CHEBI:Fibrin)) -> path(EFO:pathogenicity)
deg(a(CHEBI:Fibrin)) -> path(MESH:Virulence)

SET Evidence = "The leading causes of deaths are ARDS, septic shock with MOF, \
hemorrhage/coagulopathy (disseminated intravascular coagulopathy, \
DIC), acute heart/liver/kidney injury, and secondary bacterial \
infections (97, 101)"

path(EFO:"acute respiratory distress syndrome") pos path(MESH:Mortality)
path(MESH:"Disseminated Intravascular Coagulation") pos path(MESH:Mortality)
path(MESH:"Bacterial Infections") pos path(MESH:Mortality)
path(MESH:"Acute Kidney Injury") pos path(MESH:Mortality)
path(MESH:"Brain Injuries") pos path(MESH:Mortality)
path(HP:"Acute hepatitis") pos path(MESH:Mortality)

SET Evidence = "Elevated fibrin degradation products and D-dimers were detected \
predominantly in patients with severe disease (11, 24, 31, 43, 91 45, \
79, 85)"

SET Severity = "Severe"
deg(a(CHEBI:Fibrin)) pos path(EFO:pathogenicity)
bp(EFO:"D dimer measurement") pos path(EFO:pathogenicity)

SET Evidence = "Multivariate regression further suggests that age and D-dimer levels \
(>1 mg/L) are two 92 independent risk factors for mortality (89, 101)."

bp(EFO:"D dimer measurement") pos path(MESH:Mortality)
a(MESH:"Age of Onset") pos path(MESH:Mortality)

SET Evidence = "In the early stages of infection, puncture lung biopsies reveal the \
presence of pneumonia, edema, proteinaceous exudate with globules and \
focal hyperplasia of alveolar epithelial cells associated with patchy \
inflammatory infiltrates, and multinucleated giant cells (81)."

SET Disease_Stage = "Early"
SET MeSHAnatomy = "Alveolar Epithelial Cells"
path(DO:"focal epithelial hyperplasia") pos path(EFO:pathogenicity)
path(MESH:Inflammation) pos path(EFO:pathogenicity)
path(MESH:Edema) pos path(EFO:pathogenicity)
a(MESH:"Giant Cells") pos path(EFO:pathogenicity)
UNSET MeSHAnatomy

SET Evidence = "At the later stages, diffuse alveolar damage (DAD) is observed in \
addition to hemorrhage and some areas of interstitial fibrosis (48)."

SET Disease_Stage = "Late"
path(EFO:pathogenicity) neg a(MESH:"Alveolar Epithelial Cells")
path(EFO:pathogenicity) pos path(MESH:Hemorrhage)
path(MESH:"Lung Diseases, Interstitial") pos path(MESH:Hemorrhage)
UNSET Disease_Stage

SET Evidence = "Consistent with clinical observations, the lungs are the most injured \
organs, followed by moderate injury in the heart, liver, kidney, and \
brain."

path(DO:"COVID-19") pos path(MESH:"Lung Injury")
path(DO:"COVID-19") pos path(MESH:"Heart Injuries")
path(MESH:"Acute Kidney Injury") pos path(DO:"COVID-19")
path(MESH:"Brain Injuries") pos path(DO:"COVID-19")
path(HP:"Acute hepatitis") pos path(DO:"COVID-19")

SET Evidence = "The S protein of SARS-CoV-2 bind to human ACE2 receptors with higher \
affinity than that of the SARS-CoV virus (88)."

complex(p(HGNC:ACE2), p(COVID:S)) -- path(EFO:pathogenicity)

SET Evidence = "The S protein of coronaviruses may be cleaved by plasmin, trypsin, \
cathepsins, elastase and TMPRSSs; cleavage of S protein may mediate \
enhancement of virus entry, into bronchial epithelial cells (37)"

a(CHEBI:Plasmin) -> p(COVID:S, frag("?"))
a(CHEBI:Trypsin) -> p(COVID:S, frag("?"))
a(MESH:Cathepsins) -> p(COVID:S, frag("?"))
deg(a(MESH:proelastase)) -> p(COVID:S, frag("?"))
a(MESH:"TMPRSS2 protein, human") -> p(COVID:S, frag("?"))
SET MeSHAnatomy = "Alveolar Epithelial Cells"
p(COVID:S, frag("?")) -> path(EFO:pathogenicity)
UNSET MeSHAnatomy

SET Evidence = "Similarly, the S protein of SARS-CoV-2 harbors a furin cleavage site \
at the S1/S2 boundary. The almost ubiquitous and diverse expression of \
furin-like proteases could lead to increasing SARS-CoV-2 cell and \
tissue tropism and transmissibility, and enhance its pathogenicity \
(84)."

a(MESH:Furin) -> p(COVID:S, frag("?"))
p(COVID:S, frag("?")) -> path(EFO:pathogenicity)

SET Evidence = "The S proteins bind to ACE2 receptors after being cleaved by furin- \
like proteases. The RNA-dependent RNA polymerase (RdRp) is responsible \
for replicating SARS-CoV-2 RNA genome"

a(MESH:Furin) -> p(COVID:S, frag("?"))
p(COVID:S, frag("?")) -> complex(p(HGNC:ACE2), p(COVID:S, frag("?")))
p(COVID:ORF1ab) -> bp(GO:"viral genome replication")

SET Evidence = "In comparison with patients with mild COVID-19 (such as those who did \
not require ICU stays, did not develop ARDS or pneumonia, and who \
survived), patients with severe COVID-19 have higher comorbidities, \
including 56% for hypertension, 21% for heart diseases, 18% for \
diabetes, 12% for cerebrovascular diseases, and 7% for cancer (Table \
1) (79, 97)."

SET Severity = "Severe"
path(DO:"COVID-19") -- path(DO:hypertension)
path(DO:"COVID-19") -- path(DO:"heart disease")
path(DO:"COVID-19") -- path(DO:"diabetes mellitus")
path(DO:"COVID-19") -- path(DO:"cardiovascular system disease")
path(DO:"COVID-19") -- path(DO:"cancer")
UNSET Severity

SET Evidence = "Multivariate regression further links hypertension with increased \
incidence and fatality (85, 89, 101)."

path(DO:hypertension) pos path(MESH:Mortality)


SET Evidence = "This is accompanied by a prolonged prothrombin time particularly in \
non-- survivors (31, 79, 97, 101)."

bp(MESH:"Prothrombin Time") pos path(MESH:Mortality)

SET Evidence = "Platelet counts were decreased significantly in severe and dead \
patients (79, 97, 101)"

SET Severity = "Severe"
bp(MESH:"Platelet Count") neg path(MESH:Mortality)
UNSET Severity

SET Evidence = "71.4% of non-survivors meet the criteria of the International Society \
on Thrombosis and Haemostasis (ISTH) for disseminated intravascular \
coagulation (DIC), suggesting the coexistence of coagulation \
activation and hyper-fibrinolysis in patients with severe COVID-19 \
infection (78, 85)."

path(DO:"disseminated intravascular coagulation") pos path(MESH:Mortality)
bp(MESH:"Blood Coagulation") pos path(MESH:Mortality)


SET Evidence = "Measurements of plasmin(ogen) levels and its enzymatic activity may be \
important biomarkers of disease severity in addition to resultant \
D-dimer."

bp(EFO:"D dimer measurement") biomarkerFor path(DO:"COVID-19")
a(CHEBI:Plasmin) biomarkerFor path(DO:"COVID-19")

SET Evidence = "As demonstrated in vitro, TMPRSS2, a serine protease inhibitor blocks \
SARS-CoV-2 S protein-driven entry into cells (30)."

a(MESH:"TMPRSS2 protein, human") -| bp(GO:"viral genome replication")
UNSET PublicationType
UNSET PublicationStatus
UNSET Section
